[go: up one dir, main page]

ES2165355T3 - Trombina y procedimiento para su preparacion. - Google Patents

Trombina y procedimiento para su preparacion.

Info

Publication number
ES2165355T3
ES2165355T3 ES92890232T ES92890232T ES2165355T3 ES 2165355 T3 ES2165355 T3 ES 2165355T3 ES 92890232 T ES92890232 T ES 92890232T ES 92890232 T ES92890232 T ES 92890232T ES 2165355 T3 ES2165355 T3 ES 2165355T3
Authority
ES
Spain
Prior art keywords
thrombin
procedure
preparation
thumbin
protrombine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92890232T
Other languages
English (en)
Inventor
Johann Dr Eibl
Yendra Dr Linnau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter AG
Original Assignee
Baxter AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3529491&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2165355(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter AG filed Critical Baxter AG
Application granted granted Critical
Publication of ES2165355T3 publication Critical patent/ES2165355T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Amplifiers (AREA)
  • Revetment (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)

Abstract

LA INVENCION SE REFIERE A UNA TROMBINA DE ORIGEN HUMANO O ANIMAL QUE ESTA LIBRE DE AGENTES INFECCIOSOS Y PUEDE SER FABRICADO POR MEDIO DE LA ACTIVACION DE LA PROTROMBINA, QUE SE SOMETE A UN TRATAMIENTO DE CALENTAMIENTO PARA LA INACTIVACION DE AGENTES INFECCIOSOS.
ES92890232T 1991-11-04 1992-11-02 Trombina y procedimiento para su preparacion. Expired - Lifetime ES2165355T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0218391A AT398079B (de) 1991-11-04 1991-11-04 Präparation mit thrombinaktivität sowie verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
ES2165355T3 true ES2165355T3 (es) 2002-03-16

Family

ID=3529491

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92890232T Expired - Lifetime ES2165355T3 (es) 1991-11-04 1992-11-02 Trombina y procedimiento para su preparacion.

Country Status (19)

Country Link
US (1) US5714370A (es)
EP (1) EP0541507B1 (es)
JP (1) JP2572513B2 (es)
AT (2) AT398079B (es)
AU (1) AU645715B2 (es)
CA (1) CA2081703C (es)
CZ (1) CZ281502B6 (es)
DE (1) DE59209922D1 (es)
DK (1) DK0541507T3 (es)
ES (1) ES2165355T3 (es)
FI (1) FI104378B (es)
HR (1) HRP921171B1 (es)
HU (1) HU213867B (es)
MX (1) MX9206303A (es)
NO (1) NO312125B1 (es)
PL (1) PL170156B1 (es)
SI (1) SI9200299B (es)
SK (1) SK279193B6 (es)
YU (1) YU96192A (es)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT402891B (de) * 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
DE4137996A1 (de) * 1991-11-19 1993-05-27 Behringwerke Ag Verfahren zur herstellung eines virussicheren thrombinkonzentrates
AT399818B (de) * 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation
EP0674531A1 (de) * 1992-12-16 1995-10-04 IMMUNO Aktiengesellschaft Verfahren zur herstellung eines virussicheren biologischen präparates
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
JPH07308190A (ja) * 1994-05-18 1995-11-28 Green Cross Corp:The トロンビンの製造方法
US5506127A (en) * 1994-09-21 1996-04-09 Proba; Zbigniew Therapeutic grade thrombin produced by chromatography
GB9503750D0 (en) * 1995-02-24 1995-04-12 Common Services Agency Thrombin preparation
AT404597B (de) 1995-11-24 1998-12-28 Immuno Ag Verfahren zur herstellung von proteinen
JP3944267B2 (ja) * 1996-08-09 2007-07-11 財団法人化学及血清療法研究所 プロトロンビンの活性化方法および該方法に基づくトロンビンの製造方法
US7435425B2 (en) * 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US6066325A (en) 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
AT405608B (de) * 1997-04-08 1999-10-25 Immuno Ag Verfahren zur inaktivierung von pathogenen, insbesondere von viren, in einem biologischen material
AT405485B (de) 1997-05-28 1999-08-25 Immuno Ag Eine das vwf-propeptid enthaltende pharmazeutische präparation
AU5903000A (en) * 1999-06-29 2001-01-31 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Novel anti-thrombin peptide
US7795218B2 (en) 2001-04-12 2010-09-14 Bioaxone Therapeutique Inc. ADP-ribosyl transferase fusion variant proteins
GB0216002D0 (en) * 2002-07-10 2002-08-21 Nat Blood Authority Process and composition
US8834864B2 (en) * 2003-06-05 2014-09-16 Baxter International Inc. Methods for repairing and regenerating human dura mater
US7927626B2 (en) 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
KR20090017654A (ko) * 2006-05-31 2009-02-18 백스터 인터내셔널 인코포레이티드 척수 수술에서 세포 내성장을 통제하고 조직 재생을 조절하는 방법
TWI436793B (zh) 2006-08-02 2014-05-11 Baxter Int 快速作用之乾密封膠及其使用和製造方法
AU2008317874B2 (en) 2007-10-30 2013-12-19 Baxter Healthcare S.A. Use of a regenerative biofunctional collagen biomatrix for treating visceral or parietal defects
WO2009109194A2 (en) 2008-02-29 2009-09-11 Ferrosan A/S Device for promotion of hemostasis and/or wound healing
TWI488662B (zh) 2008-12-11 2015-06-21 Baxter Int 基於血纖維蛋白元與硫酸化多醣的製劑
KR101105026B1 (ko) * 2009-04-06 2012-01-16 김기영 다방향 굴절형 핸드 그라인더
US9039783B2 (en) 2009-05-18 2015-05-26 Baxter International, Inc. Method for the improvement of mesh implant biocompatibility
AU2010262058B2 (en) 2009-06-16 2013-08-29 Baxter Healthcare S.A. Hemostatic sponge
WO2011079336A1 (en) * 2009-12-16 2011-07-07 Baxter International Inc. Hemostatic sponge
SA111320355B1 (ar) 2010-04-07 2015-01-08 Baxter Heathcare S A إسفنجة لايقاف النزف
KR101967085B1 (ko) 2010-06-01 2019-04-08 백스터 인터내셔널 인코포레이티드 건조 및 안정한 지혈 조성물의 제조 방법
AU2011260274B2 (en) 2010-06-01 2015-07-02 Baxter Healthcare S.A. Process for making dry and stable hemostatic compositions
AU2011260260B2 (en) 2010-06-01 2015-09-03 Baxter Healthcare S.A. Process for making dry and stable hemostatic compositions
ES2938566T3 (es) 2011-10-11 2023-04-12 Baxter Int Composiciones hemostaticas
EP2766059B1 (en) 2011-10-11 2022-11-23 Baxter International Inc. Hemostatic compositions
DK2771027T3 (en) 2011-10-27 2015-11-02 Baxter Int hemostatic compositions
WO2013091895A1 (en) * 2011-12-23 2013-06-27 Merz Pharma Gmbh & Co. Kgaa Novel method for the manufacturing of di-chain proteins for use in humans
RU2657955C2 (ru) 2012-03-06 2018-06-18 Ферросан Медикал Дивайсиз А/С Контейнер под давлением, содержащий гемостатическую пасту
JP6394916B2 (ja) 2012-06-12 2018-09-26 フェロサン メディカル デバイシーズ エイ／エス 乾燥止血組成物
JP6390873B2 (ja) 2013-06-21 2018-09-19 フェッローサン メディカル ディバイス エー／エス 減圧膨張させた乾燥組成物およびそれを保持するためのシリンジ
BR112016013322B1 (pt) 2013-12-11 2020-07-21 Ferrosan Medical Devices A/S métodos para preparação de uma composição seca e para reconstituir uma composição seca, composição seca, uso de uma composição seca, e, kit
CN106999621B (zh) 2014-10-13 2020-07-03 弗罗桑医疗设备公司 用于止血和伤口愈合的干组合物
BR112017013565B1 (pt) 2014-12-24 2021-12-28 Ferrosan Medical Devices A/S Seringa para retenção e mistura de primeira e segunda substâncias
JP6747651B2 (ja) 2015-07-03 2020-08-26 フェロサン メディカル デバイシーズ エイ／エス 保管状態で真空を保持するための、及び２種の成分を混合するためのシリンジ
BR112019018010A2 (pt) 2017-03-09 2020-04-28 Baxter Healthcare Sa sistema e métodos de deposição de solventes
AU2019266529B2 (en) 2018-05-09 2024-05-23 Ethicon Inc. Method for preparing a haemostatic composition

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT350726B (de) * 1976-08-30 1979-06-11 Immuno Ag Verfahren zur herstellung einer blut- gerinnungsfoerdernden praeperation aus menschlichem blutplasma
DE2902158A1 (de) * 1979-01-20 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung von fibrinogen, einem die gerinnungsfaktoren ii, vii, ix und x enthaltenden prothrombinkomplex, antithrombin iii und einer loesung von lagerstabilen serumproteinen
US4357321A (en) * 1980-01-28 1982-11-02 Baxter Travenol Laboratories, Inc. Method and composition for treating clotting factor inhibitors
DE3019612A1 (de) * 1980-05-22 1981-11-26 Boehringer Mannheim Gmbh, 6800 Mannheim Stabilisiertes thrombinpraeparat
US4404132A (en) * 1980-05-27 1983-09-13 Cutter Laboratories, Inc. Blood coagulation promoting product
US4364861A (en) * 1980-05-27 1982-12-21 Cutter Laboratories, Inc. Blood-coagulation-promoting products and methods of preparing them
AT368883B (de) * 1980-07-22 1982-11-25 Immuno Ag Verfahren zur herstellung einer neuen blutgerinnungsfoerdernden praeparation auf basis von humanproteinen
US4480029A (en) * 1981-04-27 1984-10-30 Baxter Travenol Laboratories, Inc. Biological indicators and their use
US4495278A (en) * 1981-04-27 1985-01-22 Baxter Travenol Laboratories, Inc. Process for making novel blood clotting enzyme compositions
US4764369A (en) * 1983-07-14 1988-08-16 New York Blood Center Inc. Undenatured virus-free biologically active protein derivatives
AT385657B (de) * 1984-03-09 1988-05-10 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
US4613501A (en) * 1984-12-21 1986-09-23 New York Blood Center, Inc. Inactivation of viruses in labile blood derivatives
US4673733A (en) * 1985-04-11 1987-06-16 Sudhish Chandra Treatment of biological and pharmaceutical products adsorbed on a solid phase with virus and pyrogen inactivating agents
JPS63243032A (ja) * 1987-03-27 1988-10-07 Green Cross Corp:The トロンビンの加熱処理方法
DE3843126C3 (de) * 1988-12-22 1994-10-06 Octapharma Ag Verfahren zur Herstellung eines hochreinen Thrombinkonzentrates
DE69011136T3 (de) * 1989-01-13 2003-10-23 Mitsubishi Pharma Corp Verfahren zur Herstellung einer Protein enthaltenden Zusammensetzung.
IE73210B1 (en) * 1990-01-24 1997-05-07 Warner Lambert Co Process for the production of thrombin and high purity thrombin preparation thereby obtained
ES2131504T3 (es) * 1990-02-20 1999-08-01 Baxter Int Trombina humana purificada viricamente segura.
FR2679251B1 (fr) * 1991-07-18 1993-11-12 Nord Assoc Essor Transfusion San Procede de preparation d'un concentre de thrombine humaine destine a un usage therapeutique.
DE4137996A1 (de) * 1991-11-19 1993-05-27 Behringwerke Ag Verfahren zur herstellung eines virussicheren thrombinkonzentrates

Also Published As

Publication number Publication date
CA2081703C (en) 1999-01-19
JPH0646852A (ja) 1994-02-22
PL296460A1 (en) 1993-12-13
US5714370A (en) 1998-02-03
CZ330992A3 (en) 1993-06-16
SI9200299A (en) 1994-06-30
EP0541507A3 (en) 1993-06-16
DK0541507T3 (da) 2002-01-28
HRP921171A2 (en) 1995-08-31
MX9206303A (es) 1993-08-01
AT398079B (de) 1994-09-26
SI9200299B (sl) 2002-02-28
CZ281502B6 (cs) 1996-10-16
CA2081703A1 (en) 1993-05-05
ATA218391A (de) 1994-01-15
FI104378B (fi) 2000-01-14
YU96192A (sh) 1995-12-04
AU645715B2 (en) 1994-01-20
NO924229D0 (no) 1992-11-03
HRP921171B1 (en) 2000-02-29
NO924229L (no) 1993-05-05
SK330992A3 (en) 1998-07-08
PL170156B1 (pl) 1996-10-31
JP2572513B2 (ja) 1997-01-16
FI924975L (fi) 1993-05-05
SK279193B6 (sk) 1998-07-08
DE59209922D1 (de) 2001-11-15
EP0541507A2 (de) 1993-05-12
ATE206757T1 (de) 2001-10-15
HUT65390A (en) 1994-06-28
NO312125B1 (no) 2002-03-25
HU213867B (en) 1997-11-28
EP0541507B1 (de) 2001-10-10
AU2736192A (en) 1993-05-06
FI924975A0 (fi) 1992-11-04
HU9203366D0 (en) 1993-01-28

Similar Documents

Publication Publication Date Title
ES2165355T3 (es) Trombina y procedimiento para su preparacion.
FI946004A0 (fi) Lääketieteellisessä toimenpiteessä käytettävä trombiiniverifraktio
ES2099056T3 (es) Cepas de lactobacillus de origen humano, sus composiciones y usos de las mismas.
ES2176605T3 (es) Sutura quirurgica.
ES2067696T3 (es) Composiciones de liberacion sostenida para tratar la enfermedad periodontal.
HRP20000443B1 (en) Prevention and treatment of amyloidogenic disease
ATE238744T1 (de) Damenbinde mit parfümmikrokapseln enthaltenden klebstoff
BR0116470A (pt) éteres de imidazoquinolina substituìdos com uréia
ES2182874T3 (es) Procedimiento de tratamiento de las uñas.
IS4057A (is) Efni til að auka kyngetu
ES2173923T3 (es) Procedimiento que permite inactivar un virus en presencia de un polieter y de un agente.
BR0114912A (pt) Kahalalide f
DE3876288D1 (de) Desinfektions- und sterilisierungsmittel.
ES2094247T3 (es) Utilizacion de un desinfectante acuoso que contiene acido citrico para desactivar el virus de la hepatitis b y esporas bacterianas.
BR9911619A (pt) Pestivìrus atenuados
ES2072975T3 (es) Mezcla de esterilizante y metodo de esterilizacion.
ES2158094T3 (es) Sales de adicion de acido de compuestos de 2,3,4,5-tetrahidro-1h-3-benzazepina.
DK0975360T3 (da) Bovint respiratorisk og enterisk coronavirus som vaccine
ES2045146T3 (es) Avermectinas etiladas.
PA8498601A1 (es) Composicion anticoloracion
ES2196802T3 (es) Lactatos de citronelilo y/o de dihidrocitronelilo, su preparacion y su utilizacion.
HRP20030701A2 (en) Natural antibodies active against hiv virus
GT200100096A (es) Derivados de tropano utiles en terapia.
SE9000300D0 (sv) Surgoerande komposition
DE69319140D1 (de) 4-guanidinobutyramid zur verbesserung des blutkreislaufs

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 541507

Country of ref document: ES